ketoconazole has been researched along with Diseases of Pharynx in 12 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 8.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
"In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
"A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
"Itraconazole and fluconazole are two relatively new anti-fungal agents which are being used successfully in the treatment of oropharyngeal candidiasis." | 4.78 | Itraconazole and fluconazole in oropharyngeal candidiasis. ( Arendorf, TM; van der Bijl, P, 1993) |
" Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day." | 2.67 | Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. ( Hernández-Sampelayo, T, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Quintiliani, R | 1 |
Owens, NJ | 1 |
Quercia, RA | 1 |
Klimek, JJ | 1 |
Nightingale, CH | 1 |
Force, RW | 1 |
Nahata, MC | 1 |
Hernández-Sampelayo, T | 1 |
van der Bijl, P | 1 |
Arendorf, TM | 1 |
Walmsley, S | 1 |
King, S | 1 |
McGeer, A | 1 |
Ye, Y | 1 |
Richardson, S | 1 |
Samaranayake, YH | 1 |
Samaranayake, LP | 2 |
Tsang, PC | 1 |
Wong, KH | 1 |
Yeung, KW | 1 |
Patton, LL | 1 |
Bonito, AJ | 1 |
Shugars, DA | 1 |
Anil, S | 1 |
Ellepola, AN | 1 |
De Wit, S | 1 |
Weerts, D | 1 |
Goossens, H | 1 |
Clumeck, N | 1 |
Thamlikitkul, V | 1 |
Danpakdi, K | 1 |
Visuthisakchai, S | 1 |
Kulpreedarat, T | 1 |
Berkowitz, RJ | 1 |
Hughes, C | 1 |
Rudnick, M | 1 |
Gordon, EM | 1 |
Strandjord, S | 1 |
Cheung, NK | 1 |
Warkentin, P | 1 |
Coccia, PF | 1 |
2 reviews available for ketoconazole and Diseases of Pharynx
Article | Year |
---|---|
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; | 1993 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
5 trials available for ketoconazole and Diseases of Pharynx
Article | Year |
---|---|
Treatment and prevention of oropharyngeal candidiasis.
Topics: Adolescent; Adult; Aged; Aspergillosis; Candidiasis; Child; Child, Preschool; Clinical Trials as Top | 1984 |
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cr | 1995 |
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; C | 1994 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
Randomized controlled trial of clotrimazole troche and ketoconazole for oropharyngeal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Candidiasis; Clinical Trials as Topic; Clotrimazole; | 1988 |
5 other studies available for ketoconazole and Diseases of Pharynx
Article | Year |
---|---|
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Dru | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2001 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Ma | 1989 |
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Burkitt Lymphoma; Candidiasis; Child; Chi | 1985 |